Osteoporosis

Osteoporosis is a skeletal disorder caused by low bone mass resulting in increased bone fragility and susceptibility to fractures. Prevalence increases with age. Every person has a unique peak mass and “threshold value” under below which a bone can fracture after minor trauma. The inter-play between calcium, vitamin D, collagen, oestrogen receptors, and other factors,  determines bone peak mass.

Peak bone mass usually occurs around the age of 30 years and begins to decline thereafter. The menopause transition, and early postmenopausal years, are associated with an accelerated period of bone density loss of approx 2% annually. One of the benefits of MHT is that it can maintain bone mineral density. It can also be a treatment for osteoporosis for women in their perimenopause or early to mid-menopause.